Engineered titania nanomaterials in advanced clinical applications

• Padmavati Sahare,
• Paulina Govea Alvarez,
• Juan Manual Sanchez Yanez,
• Gabriel Luna-Bárcenas,
• Samik Chakraborty,
• Sujay Paul and
• Miriam Estevez

Beilstein J. Nanotechnol. 2022, 13, 201–218, doi:10.3762/bjnano.13.15

• delivery. Ideal drug delivery systems encompass two elements, that is, the control over drug release and the ability to target specific locations in order to reduce systemic toxicity and undesirable side effects. Porous TiO2 has shown tremendous ability to sustain a concentration of drugs within the

• demonstrated enhanced osseointegration [58]. Additionally, drug release kinetics and duration from titania nanotubes (TNTs) can be controlled by modifying nanotube dimensions, surface chemistry, or by a polymer coating on the TNT implant surface through dip coating or plasma polymerization. Losic and co

• augmenting better attachment of drug molecules, and the drug release profile was extended to more than 15 days by minimizing the burst release effect [59]. Polycaprolactone is a semi-crystalline biodegradable polymer used as a drug carrier, packaging material, and 3D scaffold for bone tissue engineering

Biocompatibility and cytotoxicity in vitro of surface-functionalized drug-loaded spinel ferrite nanoparticles

• Sadaf Mushtaq,
• Khuram Shahzad,
• Tariq Saeed,
• Anwar Ul-Hamid,
• Bilal Haider Abbasi,
• Nafees Ahmad,
• Waqas Khalid,
• Muhammad Atif,
• Zulqurnain Ali and
• Rashda Abbasi

Beilstein J. Nanotechnol. 2021, 12, 1339–1364, doi:10.3762/bjnano.12.99

• specificity with significantly higher (p < 0.005) drug release in an acidic environment (pH 5.5). The nanoparticles were highly colloidal (zeta potential = −35 to −26 mV) in deionized water, phosphate buffer saline (PBS), and sodium borate buffer (SBB). They showed elevated and dose-dependent cytotoxicity in

• applications [30]. All samples have lower PDI values (0.13–0.33) which indicates a uniform distribution of NPs in different dispersion media (Table 5). pH-dependent drug-loading and drug-release kinetics The UV–vis-based confirmation of drug (DOX and MTX) attachment to PMA-coated MFe2O4 (M = Fe, Co, Zn, Ni

• 0.5 mM of drugs for the loading on NPs. The encapsulated and loaded drug % for DOX and MTX are given in Table 6. For pH-dependent drug-release kinetics, drug-loaded NPs were dispersed in solutions with different pH values (1× PBS; pH 5.5, 6.5, and 7.4) at room temperature and the amount of release

Self-assembly of amino acids toward functional biomaterials

• Huan Ren,
• Lifang Wu,
• Lina Tan,
• Yanni Bao,
• Yuchen Ma,
• Yong Jin and
• Qianli Zou

Beilstein J. Nanotechnol. 2021, 12, 1140–1150, doi:10.3762/bjnano.12.85

• bacteria and aztreonam-encapsulated Fomc-F hydrogels antagonize Pseudomonas aeruginosa and enhance Fomc-F antimicrobial activity. Salicylic acid is loaded in Fmoc-ʟ-phenylalanine hydrogel, which can play a role against Gram-positive bacteria, and the drug release behavior changes at different temperature

• conformational changes through various mechanisms, such as protonation, charge inversion, or chemical bond cleavage, promoting tumor-specific cellular uptake or drug release [82]. Sun et al. [83] coupled tryptophan-glycine (WG) to hydrophobic porphyrins (P) by an amidation reaction to obtain pH-responsive

pH-driven enhancement of anti-tubercular drug loading on iron oxide nanoparticles for drug delivery in macrophages

• Karishma Berta Cotta,
• Sarika Mehra and
• Rajdip Bandyopadhyaya

Beilstein J. Nanotechnol. 2021, 12, 1127–1139, doi:10.3762/bjnano.12.84

• . Furthermore, only the former (pH 5 system) exhibited a desirable slower drug release profile, compared to the free drug. NOR-coated IONPs also enable a 22 times higher drug accumulation in macrophages, compared to identical extracellular concentrations of the free drug. Thus, lowering the drug coating pH to 5

• imparts multiple benefits – improved IONP stability, enhanced drug coating, higher drug uptake in macrophages at reduced toxicity and slower drug release. Keywords: drug-nanoparticle interactions; drug uptake; intra-macrophage; iron oxide nanoparticles; norfloxacin; Introduction Nanoparticles have taken

• biocompatibility and magnetic properties, have found applications in drug delivery, magnetic resonance imaging and treatment of iron deficiencies [3][4][5][6]. The property of hyperthermia has been found to be beneficial in localized drug release, particularly in cancer therapy [7]. In anti-cancer therapy, IONPs

Comprehensive review on ultrasound-responsive theranostic nanomaterials: mechanisms, structures and medical applications

• Sepand Tehrani Fateh,
• Lida Moradi,
• Elmira Kohan,
• Michael R. Hamblin and
• Amin Shiralizadeh Dezfuli

Beilstein J. Nanotechnol. 2021, 12, 808–862, doi:10.3762/bjnano.12.64

• lack the ability to release the cargo at the desired site in a well-controlled manner. Therefore, smart DDS have been developed to provide drug release at the target site in a spatially and temporally controlled manner, preserve the drug/agent in the target site for a longer time, increase the

• several review articles [3][7][10][11]. Endogenous or internal stimuli can be hard to control because of the heterogeneous disease environment. On the other hand, the use of exogenous or external stimuli may cause tissue damage and the depth of penetration may not be sufficient to trigger drug release

• significant advantages of stimuli-responsive DDS is the precise spatial and temporal control of drug release in response to the application of exogenous or endogenous stimuli, including US [3]. Ultrasound is traditionally used in diagnostic medicine but now it is finding a place in drug delivery in

Recent progress in actuation technologies of micro/nanorobots

• Ke Xu and
• Bing Liu

Beilstein J. Nanotechnol. 2021, 12, 756–765, doi:10.3762/bjnano.12.59

• swing and spiral motion. At the same time, by applying a suitable magnetic field, the nanoeel can be accurately guided to a target location for drug release. Under a magnetic field of 10 mT and 7 Hz, drug delivery to cancer cells could be achieved. The efficiency of killing cancer cells is 35% in the

• drug release mode and 10% in the swimming mode. The results of this research quantitatively confirmed the ability of using nanorobots for targeted delivery of medicines. This will promote the use of nanorobots in clinical practice and provide a solid foundation for future research. For the treatment of

• schemes were proposed. The first is the electromagnetic actuation of microrobots, which is based on a pair of Helmholtz and Maxwell electric coils. The second is acoustic bubble actuation for drug release. When two columnar bubbles of different lengths are simultaneously exposed to sound waves, only the

Recent progress in magnetic applications for micro- and nanorobots

• Ke Xu,
• Shuang Xu and
• Fanan Wei

Beilstein J. Nanotechnol. 2021, 12, 744–755, doi:10.3762/bjnano.12.58

• trigger drug release. The fabrication method of Chen’s team yielded not only easily adjustable length and diameter of the nanowires, but also excellent interface coupling between the piezoelectric and magnetostrictive phases. It enabled precise magnetic manipulation on patterned surfaces and 3D swimming

The impact of molecular tumor profiling on the design strategies for targeting myeloid leukemia and EGFR/CD44-positive solid tumors

• Nikola Geskovski,
• Nadica Matevska-Geshkovska,
• Simona Dimchevska Sazdovska,
• Marija Glavas Dodov,
• Kristina Mladenovska and
• Katerina Goracinova

Beilstein J. Nanotechnol. 2021, 12, 375–401, doi:10.3762/bjnano.12.31

• migrate toward other target molecules to form multimeric bonds, thus enhancing the robustness of the bonding among the nanoscale carriers and target cells. In addition to the sliding targeting ligands, the authors enabled stimuli-responsive drug release by incorporating i-motif DNA in the nanoscale

• , resulting in a burst release of the core contents. In this way, the authors managed to achieve a stimuli-responsive sequential drug release pattern. IM will be released in the cytoplasm from the dextrane complexes due to the activity of intracellular protease while the nilotinib–chitosan complexes will be

Doxorubicin-loaded gold nanorods: a multifunctional chemo-photothermal nanoplatform for cancer management

• Uzma Azeem Awan,
• Abida Raza,
• Shaukat Ali,
• Rida Fatima Saeed and
• Nosheen Akhtar

Beilstein J. Nanotechnol. 2021, 12, 295–303, doi:10.3762/bjnano.12.24

• urgently needed to kill cancerous cells without damaging normal cells or tissues. One approach is to selectively remove cancer cells using the advanced drug delivery systems. These carrier systems hold sufficient amounts of the drug with prolonged circulation time and sustained drug release at the tumor

• conversion of absorbed NIR light to heat. In cancer intervention, NIR-mediated photothermal therapy is gaining more attention due to the deep tissue penetration with minimal absorbance by healthy tissues [15][16]. Gold nanorods are potential delivery carriers for sustained drug release in response to an

• shifted by approximately 4 nm (Figure 2). The stability of PSS-GNRs after NIR laser exposure was sufficient for photothermal therapy. In vitro DOX release after NIR irradiation Drug release from PSS-GNRs can be easily controlled with NIR laser irradiation. The cumulative DOX release almost doubled after

PEG/PEI-functionalized single-walled carbon nanotubes as delivery carriers for doxorubicin: synthesis, characterization, and in vitro evaluation

• Shuoye Yang,
• Zhenwei Wang,
• Yahong Ping,
• Yuying Miao,
• Yongmei Xiao,
• Lingbo Qu,
• Lu Zhang,
• Yuansen Hu and
• Jinshui Wang

Beilstein J. Nanotechnol. 2020, 11, 1728–1741, doi:10.3762/bjnano.11.155

• evaluated in terms of drug loading, in vitro release, cytotoxicity towards MCF-7 cells and cellular uptake. The results showed that all CNT carriers had a high drug loading capacity. In comparison with CNTs-COOH and CNTs-PEG, CNTs-PEG-PEI showed a more rapid drug release under acidic conditions and a higher

• ) and encapsulation efficiency (EE) were determined as: LE = weight of encapsulated DOX/weight of DOX-loaded carriers and EE (%) = weight of encapsulated DOX/weight of the total DOX·100%. In vitro drug release The release of DOX from the nanocarriers was examined in PBS at pH 7.4 and pH 5.0 [34

• modification with PEG or PEI [40]. It should be noted that LE and EE of CNT carriers in this study are higher than those of other nanocarriers such as mesoporous silica nanoparticles (MSNs) or liposomes [39]. In vitro drug release Due to the encapsulation in the nanocarriers after drug loading, a premature

Transient coating of γ-Fe₂O₃ nanoparticles with glutamate for its delivery to and removal from brain nerve terminals

• Konstantin Paliienko,
• Artem Pastukhov,
• Michal Babič,
• Daniel Horák,
• Olga Vasylchenko and
• Tatiana Borisova

Beilstein J. Nanotechnol. 2020, 11, 1381–1393, doi:10.3762/bjnano.11.122

• drug release from nanoparticles to manipulate neuronal cells [9][15]. Release of receptor agonists and antagonists from thermally sensitive magnetoliposomes loaded with iron oxide magnetic nanoparticles can be remotely controlled by weak alternating magnetic fields facilitating the modulation of

Photothermally active nanoparticles as a promising tool for eliminating bacteria and biofilms

• Mykola Borzenkov,
• Piersandro Pallavicini,
• Angelo Taglietti,
• Laura D’Alfonso,
• Maddalena Collini and
• Giuseppe Chirico

Beilstein J. Nanotechnol. 2020, 11, 1134–1146, doi:10.3762/bjnano.11.98

• drug release [41][42], in addition to new quantitative tools for biochemical analysis [43] and photothermally induced cell stimulation [44][45]. Since bacteria and biofilm photothermal ablation is another promising application that is currently being widely investigated, this review will highlight the

Applications of superparamagnetic iron oxide nanoparticles in drug and therapeutic delivery, and biotechnological advancements

• Maria Suciu,
• Corina M. Ionescu,
• Alexandra Ciorita,
• Septimiu C. Tripon,
• Dragos Nica,
• Hani Al-Salami and
• Lucian Barbu-Tudoran

Beilstein J. Nanotechnol. 2020, 11, 1092–1109, doi:10.3762/bjnano.11.94

• applications [65][66]. Some authors state that SPIONs having sizes between 5 and 10 nm are best for certain slow drug release treatments [46], however, others report that these ultrasmall SPIONs are dangerous due to their large in-tissue dispersity [67]. Other reports suggest that very small (less than 10 nm

• release at the targeted site. A functionalization that permits only adsorption can lead to premature drug release [33][46][80]. Mojica Pisciotti and co-workers [39] studied the effects of dextran and PEG coatings on two animal kidney cell lines and showed that dextran-coated SPIONs are not cytotoxic even

• PVA or PEG, for drug release studies [33][76] because the hydrophobic polymers are rapidly uptaken by macrophages [85]. SPIONs coated with a mixture of PVA and polyvinyl amine were shown to induce very active mitochondrial and endocytic processes in cells and to be highly toxic to cells due to the

A 3D-polyphenylalanine network inside porous alumina: Synthesis and characterization of an inorganic–organic composite membrane

• Jonathan Stott and
• Jörg J. Schneider

Beilstein J. Nanotechnol. 2020, 11, 938–951, doi:10.3762/bjnano.11.78

• well as the mechanisms of gel formation have been studied in detail. Hydrophilic gels with functional side groups enable stimuli-responsive hydrogels with interesting properties with regards to drug release systems. A drawback of these gels is their low mechanical stability, which can however be

• -grafted gel might be interesting in membrane separation technology or supported drug release/adsorption systems. We investigate the ability of polyphenylalanine to form organo-gels in situ within a porous inorganic environment with respect to different volume fractions of DCM in the solvent mixture. We

Luminescent gold nanoclusters for bioimaging applications

• Nonappa

Beilstein J. Nanotechnol. 2020, 11, 533–546, doi:10.3762/bjnano.11.42

• be identical with a fast release up to 6 h and a slow release up to 20 h in PBS buffer, possibly due to diffusion-driven drug release. DPML-MF remained stable in human blood serum up to 24 h. DPML-MF showed a significant effect on HeLa, HepG2 and A375 cell lines with IC50 values 200-fold higher

Multilayer capsules made of weak polyelectrolytes: a review on the preparation, functionalization and applications in drug delivery

• Varsha Sharma and
• Anandhakumar Sundaramurthy

Beilstein J. Nanotechnol. 2020, 11, 508–532, doi:10.3762/bjnano.11.41

• drug release time could be extended by increasing the crystal size and thickness of the multilayer films. Alternatively, the protein aggregates or DNA could also be used as templates to encapsulate them in PLL-succinylated PLL layers for model viral assembly or gene transfer [66]. Another way of

Nanoarchitectonics: bottom-up creation of functional materials and systems

• Katsuhiko Ariga

Beilstein J. Nanotechnol. 2020, 11, 450–452, doi:10.3762/bjnano.11.36

• ] gives insight into this interesting field of research which has great potential. The nanoarchitectonics concept has been applied for various bio-related applications, for example, in the small-protein-induced cellular uptake of complex nanohybrids [30], the controlled drug release from layered double

Interactions at the cell membrane and pathways of internalization of nano-sized materials for nanomedicine

• Valentina Francia,
• Daphne Montizaan and
• Anna Salvati

Beilstein J. Nanotechnol. 2020, 11, 338–353, doi:10.3762/bjnano.11.25

• intracellular locations or to promote drug release in cells. 4 Challenges in studying endocytosis of nano-sized materials in vitro While studying the interactions between nanomaterials and cells is extremely challenging to perform in vivo, in vitro studies can help to unravel the mechanisms involved in their

Facile biogenic fabrication of hydroxyapatite nanorods using cuttlefish bone and their bactericidal and biocompatibility study

• Satheeshkumar Balu,
• Manisha Vidyavathy Sundaradoss,
• Swetha Andra and
• Jaison Jeevanandam

Beilstein J. Nanotechnol. 2020, 11, 285–295, doi:10.3762/bjnano.11.21

• loading capacity and slow drug release in drug delivery systems for progressive advancement in osteoporosis and bone tumor treatments [17]. Various studies have reported the synthesis procedure of Hap nanoparticles from annealed cuttlefish bone using a hydrothermal method, which yields calcium oxide (CaO

Rational design of block copolymer self-assemblies in photodynamic therapy

• Maxime Demazeau,
• Laure Gibot,
• Anne-Françoise Mingotaud,
• Patricia Vicendo,
• Clément Roux and
• Barbara Lonetti

Beilstein J. Nanotechnol. 2020, 11, 180–212, doi:10.3762/bjnano.11.15

• the production of ROS upon irradiation. Stimuli-responsive vectors This strategy has been examined a lot during the last years, in a general manner for nanomedicine but also for PDT. As already explained above, the principle is to benefit from the biological medium environment to trigger the drug

• release (the PS for PDT). The decrease in pH value in cancer tissues has been regularly used in nanomedicine to break a pH-sensitive bond leading to the dissociation of the vector and the subsequent release of the drug [80]. Recently, several studies focused on hypoxia, which might be considered as a

Fully amino acid-based hydrogel as potential scaffold for cell culturing and drug delivery

• Dávid Juriga,
• Evelin Sipos,
• Orsolya Hegedűs,
• Gábor Varga,
• Miklós Zrínyi,
• Krisztina S. Nagy and
• Angéla Jedlovszky-Hajdú

Beilstein J. Nanotechnol. 2019, 10, 2579–2593, doi:10.3762/bjnano.10.249

• established. Using metoprolol as a model drug, cell proliferation and drug release kinetics were studied at different LYS contents and in the presence of thiol groups. The optimal ratio of cross-linkers for the proliferation of periodontal ligament cells was found to be 60−80% LYS and 20−40% CYS. The

• reductive conditions resulted in an increased drug release due to the cleavage of disulfide bridges in the hydrogels. Consequently, these hydrogels provide new possibilities in the fields of both tissue engineering and controlled drug delivery. Keywords: biocompatibility; cystamine; hydrogel; lysine; poly

• improve the pharmacological and therapeutic properties of various drugs [28]. By applying such microcarriers, the drug release kinetics can be controlled. Among the anionic amino acids, glutamic acid was previously used for the preparation of polymer-based microcarriers [33]. However, there are only

Bombesin receptor-targeted liposomes for enhanced delivery to lung cancer cells

• Mohammad J. Akbar,
• Pâmela C. Lukasewicz Ferreira,
• Melania Giorgetti,
• Leanne Stokes and
• Christopher J. Morris

Beilstein J. Nanotechnol. 2019, 10, 2553–2562, doi:10.3762/bjnano.10.246

• these nanocarriers, particularly with regards to their efficiency of carrying chemotherapeutic agents into the cell. Poor intracellular accumulation of nanocarriers can be improved through targeted and triggered drug release, for example through the incorporation of temperature-sensitive [32] or light

Design of a nanostructured mucoadhesive system containing curcumin for buccal application: from physicochemical to biological aspects

• Sabrina Barbosa de Souza Ferreira,
• Gustavo Braga,
• Évelin Lemos Oliveira,
• Jéssica Bassi da Silva,
• Hélen Cássia Rosseto,
• Lidiane Vizioli de Castro Hoshino,
• Mauro Luciano Baesso,
• Wilker Caetano,
• Craig Murdoch,
• Helen Elizabeth Colley and
• Marcos Luciano Bruschi

Beilstein J. Nanotechnol. 2019, 10, 2304–2328, doi:10.3762/bjnano.10.222

• for their chemical, rheological, mechanical and mucoadhesive characteristics. We also measured the in vitro drug release profile, permeation and the cytotoxic potential of these systems. Results and Discussion Interaction studies of curcumin in mucoadhesive nanostructured systems As CUR is highly

• fluorescence quenching, using iodide as a hydro-soluble suppressor [2][52][53][54]. The studies were performed at 25 °C (room and administration temperature) and 37 °C (body temperature). Using this assay, it is possible to evaluate the location of CUR in the polymeric system during drug release and to

• with the mechanical and rheological characteristics observed. One of the replicate images is showed in Figure 9B. In vitro drug release profile During the development of drug delivery systems for buccal application, in vitro drug release is highly important and is considered a prerequisite for

Targeted therapeutic effect against the breast cancer cell line MCF-7 with a CuFe₂O₄/silica/cisplatin nanocomposite formulation

• B. Rabindran Jermy,
• Vijaya Ravinayagam,
• Widyan A. Alamoudi,
• Dana Almohazey,
• Hatim Dafalla,
• Lina Hussain Allehaibi,
• Abdulhadi Baykal,
• Muhammet S. Toprak and
• Thirunavukkarasu Somanathan

Beilstein J. Nanotechnol. 2019, 10, 2217–2228, doi:10.3762/bjnano.10.214

• expected health crisis [1]. However, the single modal drug delivery system is hampered by low bioavailability (about 5–10%), burst release, and lower target efficiency. Multifunctional theranostic nanoparticles that can respond to an external magnetic field for drug release and assist in bioimaging

• for 30 min. A droplet (5 µL) of diluted suspension was deposited in a 300-mesh pure carbon grid and then kept in a pumping station for 1 h for further drying. The grids were examined by the JEM2100F instrument from JEOL. Drug release study The cumulative cisplatin release was studied using CuFe2O4

• and 600 nm shows the presence of octahedral coordinated Pt species (Figure 6b). The presence of such strong bonds of tetrahedral and octahedral Pt species indicates the high dispersity and interaction of Pt on HYPS silica support. The drug release ability of CuFe2O4/HYPS was compared with two

Incorporation of doxorubicin in different polymer nanoparticles and their anticancer activity

• Sebastian Pieper,
• Hannah Onafuye,
• Dennis Mulac,
• Jindrich Cinatl Jr.,
• Mark N. Wass,
• Martin Michaelis and
• Klaus Langer

Beilstein J. Nanotechnol. 2019, 10, 2062–2072, doi:10.3762/bjnano.10.201

• -like kinetics of the other preparations. In neuroblastoma cells, doxorubicin-loaded PLGA-PEG nanoparticles (presumably due to their small size) and PLGA nanoparticles prepared by solvent displacement at pH 7 (presumably due to their high drug load and superior drug release kinetics) exerted the

• their anticancer activity at the cellular level. Optimised preparation methods resulted in PLGA nanoparticles characterised by increased drug load, controlled drug release, and high anticancer efficacy. The design of drug-loaded nanoparticles with optimised anticancer activity at the cellular level is

• an important step in the development of improved nanoparticle preparations for anticancer therapy. Further research is required to understand under which circumstances nanoparticles can be used to overcome efflux-mediated resistance in cancer cells. Keywords: cancer; doxorubicin; drug release